12:00 AM
 | 
Jan 23, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Lundbeck, Merck sales and marketing update

Lundbeck launched Sycrest asenapine in the U.K. to treat moderate to severe manic episodes associated with bipolar I disorder. The retail price is £102.60 ($157.03)...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >